4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((R)-2-amino-3-phenylpropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol

ID: ALA1098938

PubChem CID: 11857236

Max Phase: Preclinical

Molecular Formula: C24H27N7O3

Molecular Weight: 461.53

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)Cc3ccccc3)cc21

Standard InChI:  InChI=1S/C24H27N7O3/c1-4-31-18-13-19(33-14-16(25)12-15-8-6-5-7-9-15)27-17(10-11-24(2,3)32)20(18)28-23(31)21-22(26)30-34-29-21/h5-9,13,16,32H,4,12,14,25H2,1-3H3,(H2,26,30)/t16-/m1/s1

Standard InChI Key:  YFXZFROOGCONFB-MRXNPFEDSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    2.1766  -11.2890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2009   -9.2478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6954   -8.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4759   -8.8617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4585   -9.6877    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6673   -9.9250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4549   -7.8023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3761   -9.2302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4003  -10.0569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6838   -9.6435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6867   -8.8130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4021   -8.4039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8969   -9.8935    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1151   -9.6440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1124   -8.8218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8943   -8.5666    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9202  -10.7182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6461  -11.1103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4072   -7.5789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4125   -6.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4167   -5.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7043   -5.5089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1332   -5.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4208   -5.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0313  -10.0549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0326  -10.8799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7477  -11.2913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7490  -12.1163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4615  -10.8777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1735  -12.1136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8878  -12.5249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6026  -12.1112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5986  -11.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8838  -10.8744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 13 17  1  0
 14  9  1  0
 17 18  1  0
  4  5  1  0
 12 19  1  0
  9 10  2  0
 19 20  3  0
  5  6  1  0
 20 21  1  0
 10 11  1  0
 21 22  1  0
  6  2  2  0
 21 23  1  0
 11 12  2  0
 21 24  1  0
 12 15  1  0
 10 25  1  0
 14 15  2  0
 25 26  1  0
 26 27  1  0
  3  7  1  0
 27 28  1  0
  3  4  2  0
 27 29  1  1
 29  1  1  0
  2  8  1  0
  1 30  2  0
 13 14  1  0
 30 31  1  0
 15 16  1  0
 31 32  2  0
 16  8  2  0
 32 33  1  0
  8 13  1  0
 33 34  2  0
 34  1  1  0
M  END

Associated Targets(Human)

AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.53Molecular Weight (Monoisotopic): 461.2175AlogP: 2.15#Rotatable Bonds: 7
Polar Surface Area: 151.13Molecular Species: BASEHBA: 10HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.26CX Basic pKa: 9.28CX LogP: 2.89CX LogD: 1.03
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -0.76

References

1. Rouse MB, Seefeld MA, Leber JD, McNulty KC, Sun L, Miller WH, Zhang S, Minthorn EA, Concha NO, Choudhry AE, Schaber MD, Heerding DA..  (2009)  Aminofurazans as potent inhibitors of AKT kinase.,  19  (5): [PMID:19179070] [10.1016/j.bmcl.2009.01.002]

Source